Virtual Screening-Guided Magnesium Lithospermate B Targeting Galectin-3: Anti-Hepatocellular Carcinoma Effects and Underlying Mechanisms

LI Jiang, LIN Junyu, CAO Mengqiu, TANG Haoning, LI Hao

Journal of Hunan Normal University(Medical Science) ›› 2026, Vol. 23 ›› Issue (2) : 1-8.

PDF(3872 KB)
PDF(3872 KB)
Journal of Hunan Normal University(Medical Science) ›› 2026, Vol. 23 ›› Issue (2) : 1-8.
Basic Medicine

Virtual Screening-Guided Magnesium Lithospermate B Targeting Galectin-3: Anti-Hepatocellular Carcinoma Effects and Underlying Mechanisms

  • LI Jiang1#, LIN Junyu2#, CAO Mengqiu1, TANG Haoning1, LI Hao1
Author information +
History +

Abstract

Objective To investigate the expression and prognostic relevance of galectin-3(Gal-3) in hepatocellular carcinoma (HCC), to identify Gal-3-targeting inhibitors through virtual screening followed by in vitro validation, and to preliminarily elucidate the underlying mechanisms. Methods Gal-3 expression and its association with prognosis in HCC were analyzed using The Cancer Genome Atlas (TCGA) and the Human Protein Atlas (HPA) databases. Candidate inhibitors were obtained by docking the TargetMol L4000 compound library using Schrödinger. HCC cell lines were treated with different concentrations of inhibitors for 24 h and 48 h. Cell viability, proliferation, and migration were assessed using Cell Counting Kit-8(CCK-8), 5-ethynyl-2′-deoxyuridine (EdU) incorporation, and wound-healing assays, respectively, followed by gene correlation analysis. Results Compared with normal liver tissues, Gal-3 expression was significantly increased in HCC tissues (P<0.05), and high Gal-3 expression was negatively associated with overall survival (P<0.01). Virtual screening yielded 105 candidate small molecules, and magnesium lithospermate B (MLB) was selected as the representative compound. In vitro assays confirmed that MLB significantly inhibited colony formation, proliferation, and migration of HCC cells. Differential expression and correlation analyses showed that ADRA1A and ADRB2 were negatively correlated with Gal-3 expression (r=-0.26 and -0.16, respectively; both P<0.01). Conclusion Gal-3 is highly expressed in HCC and is associated with poor prognosis. MLB may suppress HCC cell proliferation and migration by targeting Gal-3, potentially through upregulation of ADRA1A and ADRB2, providing experimental evidence and a candidate agent for Gal-3-targeted therapy for HCC.

Key words

hepatocellular carcinoma / galectin-3 / small molecule inhibitors / magnesium lithospermate B / mechanism of action

Cite this article

Download Citations
LI Jiang, LIN Junyu, CAO Mengqiu, TANG Haoning, LI Hao. Virtual Screening-Guided Magnesium Lithospermate B Targeting Galectin-3: Anti-Hepatocellular Carcinoma Effects and Underlying Mechanisms[J]. Journal of Hunan Normal University(Medical Science). 2026, 23(2): 1-8

References

[1] MCGLYNN KA, PETRICK JL, GROOPMAN JD.Liver cancer: progress and priorities[J]. Cancer Epidemiol Biomarkers Prev, 2024, 33(10): 1261-1272.
[2] SINGAL AG, KANWAL F, LLOVET JM.Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy[J]. Nat Rev Clin Oncol, 2023, 20(12): 864-884.
[3] RUMGAY H, ARNOLD M, FERLAY J, et al.Global burden of primary liver cancer in 2020 and predictions to 2040[J]. J Hepatol, 2022, 77(6): 1598-1606.
[4] KOKUDO N, KOKUDO T, HASEGAWA K.Role of liver resection for hepatocellular carcinoma with vascular invasion: emerging evidence from western countries[J]. Liver Cancer, 2021, 10(5): 404-406.
[5] REIG M, FORNER A, RIMASSA L, et al.BCLC strategy for: prognosis prediction and treatment recommendation: the 2022 update[J]. J Hepatol, 2022, 76(3): 681-693.
[6] WANG Y, DENG BC.Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers[J]. Cancer Metastasis Rev, 2023, 42(3): 629-652.
[7] NANGIA-MAKKER P, HOGAN V, BALAN V, et al.Chimeric galectin-3 and collagens: biomarkers and potential therapeutic targets in fibroproliferative diseases[J]. J Biol Chem, 2022, 298(12): 102622.
[8] BOUTIN L, DEPRET F, GAYAT E, et al, . Galectin-3 in kidney diseases: from an old protein to a new therapeutic target[J]. Int J Mol Sci, 2022, 23(6): 3124.
[9] PEDROSA LF, RAZ A, FABI JP.The complex biological effects of pectin: galectin-3 targeting as potential human health improvement?[J]. Biomolecules, 2022, 12(2): 289.
[10] SONG M, PAN Q, YANG J, et al.Galectin-3 favours tumour metastasis via the activation of β-catenin signalling in hepatocellular carcinoma[J]. Br J Cancer, 2020, 123(10): 1521-1534.
[11] CHOI MJ, YOU TM, JANG YJ.Galectin-3 plays an important role in BMP7-induced cementoblastic differentiation of human periodontal ligament cells by interacting with extracellular components[J]. Stem Cells Int, 2023, 2023: 5924286.
[12] SELENE II, OZEN M, PATEL RA.Hepatocellular carcinoma: advances in systemic therapy[J]. Semin Intervent Radiol, 2024, 41(1): 56-62.
[13] SINGAL AG, LLOVET JM, YARCHOAN M, et al.AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma[J]. Hepatology, 2023, 78(6): 1922-1965.
[14] FU Y, MACCIONI L, WANG XW,, et al. Alcohol-associated liver cancer[J]. Hepatology, 2024, 80(6): 1462-1479.
[15] KOSHY A.Evolving global etiology of hepatocellular carcinoma (HCC): insights and trends for 2024[J]. J Clin Exp Hepatol, 2025, 15(1): 102406.
[16] JANOTA B, SZYMANEK B.The influence of diet and its components on the development and prevention of hepatocellular carcinoma (HCC)[J]. Cancers (Basel), 2024, 16(5): 1030.
[17] CHENG TL, LIN ZY, LIAO KY, et al.Magnesium lithospermate B attenuates high-fat diet-induced muscle atrophy in C57BL/6J mice[J]. Nutrients, 2021, 14(1): 104.
[18] FAN C, QIN K, IROEBGU CD, et al.Magnesium lithospermate B enhances the potential of human-induced pluripotent stem cell-derived cardiomyocytes for myocardial repair[J]. Chin Med J (Engl), 2024, 137(15): 1857-1869.
[19] LIN L, SHEN D, SU Y, et al.Magnesium lithospermate B protects against ischemic AKI-to-CKD progression via regulating the KLF5/CDK1/Cyclin B1 pathway[J]. Phytomedicine, 2025, 142: 156765.
[20] ZUO XL, CHEN ZQ, WANG JF, et al.MiR-337-3p suppresses the proliferation and invasion of hepatocellular carcinoma cells through targeting JAK2[J]. Am J Cancer Res, 2018, 8(4): 662-674.
[21] REZENDE CP, MARTINS OLIVEIRA BRITO PK, PESSONI AM, et al. Altered expression of genes related to innate antifungal immunity in the absence of galectin-3[J]. Virulence, 2021, 12(1): 981-988.
PDF(3872 KB)

Accesses

Citation

Detail

Sections
Recommended

/

〈 〉